首页 | 官方网站   微博 | 高级检索  
     

黄芪甲苷氯化钠注射液治疗冠心病心绞痛220例安全性及有效性评价
引用本文:罗洋,邹澍宣,黄宇虹.黄芪甲苷氯化钠注射液治疗冠心病心绞痛220例安全性及有效性评价[J].天津中医药大学学报,2008,27(1):11-14.
作者姓名:罗洋  邹澍宣  黄宇虹
作者单位:1. 天津中医药大学,300193
2. 天津中医药大学第二附属医院,300150
摘    要:目的]客观评价黄芪甲苷氯化钠注射液治疗冠心病心绞痛的有效性和安全性.方法]试验组给予黄芪甲苷氯化钠注射液,对照组给予丹参注射液,疗程14 d,分别对心电图疗效、硝酸甘油停减率、中医证候疗效的变化进行观察.结果]黄芪甲苷氯化钠注射液能够改善心电图表现,心电图疗效试验组优于对照组,具有显著性差异(P<0.05);具有改善中医证候疗效的作用(P<0.05),特别是气虚血瘀证患者疗效显著(P<0.05);硝酸甘油用量停减率,两组比较差异无统计学意义(P>0.05);试验过程中,试验组未发生不良事件和不良反应.结论]黄芪甲苷氯化钠注射液治疗冠心病心绞痛安全有效.

关 键 词:黄芪甲苷  冠心病  心绞痛  安全性  有效性  临床评价  黄芪甲苷  氯化钠注射液  治疗  冠心病心绞痛  安全性  有效性评价  coronary  heart  disease  injection  sodium  chloride  glycoside  efficacy  safety  不良反应  不良事件  发生  过程  试验  统计学意义  比较差异  用量
文章编号:1673-9043(2008)01-0011-04
收稿时间:2007-06-20
修稿时间:2007年6月20日

Evaluation of safety and efficacy of astragali glycoside sodium chloride injection on treating heartstroke of coronary heart disease
LUO Yang,ZOU Shu-xuan and HUANG Yu-hong.Evaluation of safety and efficacy of astragali glycoside sodium chloride injection on treating heartstroke of coronary heart disease[J].Journal of Tianjin University of Traditonal Chinese Medicine,2008,27(1):11-14.
Authors:LUO Yang  ZOU Shu-xuan and HUANG Yu-hong
Affiliation:The Tianjin University of TCM, Tianjin 300193, China
Abstract:Objective] To evaluate the safety and efficacy of astragali glycoside sodium chloride injection on treatingheartstroke ofcoronaryheart disease.Methods] The patients oftreatment group was administrated to astragali glycoside sodium chloride injection and that of control group was administrated to Salvia miltiorrhiza injection.The course of treatment was fourteen days.To observe the electrocardiogram effect,nitroglycerol stopping and decreasing rate,curative effect of TCM syndrome.Results] The astragali glycoside sodium chloride injection may improve the electrocardiogram and curative effect of TCMsyndrome.The patients of treatment group had obviously an advantage than that of control group on the improvement of electrocardiogram (P<0.05).The patients of treatment group had obviously an advantage than that of control group on the improvement of TCMsyndrome (P<0.05).The patients of treatment group hadn't obviously an advantage than that of control group on the improvement of nitroglycerol stopping and decreasing rate (P>0.05).The patients of treatment group hadn't badness incident and adverse effect.Conclusion] The astragali glycoside sodium chloride injection was safe and effective to treating heartstroke of coronary heart disease.
Keywords:astragali glycoside sodium chloride  coronary heart disease  heartstroke  safety  efficacy  clinical evaluation
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《天津中医药大学学报》浏览原始摘要信息
点击此处可从《天津中医药大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号